Form 4 for PMCB PharmaCyte Biotech, Inc.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001683168-26-000148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-07 | 2026-01-05+ | PMCB | Silverman Joshua | CEO, Pres, Dir | P - Purchase | $0.803 | +100.0K | 416.2K | +32% | +$80.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | P | A | 30,000 | $0.79 | 376,250 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-05 | P | A | 30,000 | $0.78 | 346,250 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-07 | P | A | 40,000 | $0.83 | 416,250 | D | — | — |